| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.003 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |